• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

October 2023

home / publications / evidence-based-oncology / october-2023
IVBM logo | Image credit: AJMC

FROM THE EDITOR IN CHIEF: Days of Future Past

Joseph Alvarnas, MD
October 27th 2023
ArticleFROM THE EDITORS
IVBM logo | Image credit: AJMC

Collaboration Is Key to Execute Value-Based Care for Patients With Cancer

Rose McNulty
October 27th 2023
ArticleIVBM COVERAGE

Coverage of the Institute for Value-Based Medicine session with Zangmeister Cancer Center, Columbus, Ohio.

IVBM logo | Image credit: AJMC

Novel Therapies Have Significantly Improved Melanoma Outcomes, With More Exciting Options to Come

Laura Joszt, MA
October 27th 2023
ArticleIVBM COVERAGE

Coverage from the Institute for Value-Based Medicine session with Minnesota Oncology.

IVBM logo | Image credit: AJMC

Multiple Perspectives of Managing Cancer From the Multidisciplinary Team at Vanderbilt

Laura Joszt, MA
October 26th 2023
ArticleIVBM COVERAGE

Coverage from the Institute for Value-Based Medicine event with Vanderbilt University Medical Center.

IVBM logo | Image credit: AJMC

Raising the Bar for Precision Oncology and Clinical Research in a Community Practice Setting

Mary Caffrey
October 26th 2023
ArticleIVBM COVERAGE

Coverage from the Institute for Value-Based Medicine session with Florida Cancer Specialists & Research Institute.

SAP logo | image credit: AJMC

Perspectives on EOM: What Makes Sense Moving Forward

Pearl Steinzor;Mary Caffrey
October 25th 2023
ArticleFROM OUR PARTNERS
SAP logo | image credit: AJMC

Business Highlights From Partners in Community Oncology

AJMC Staff
October 25th 2023
ArticleFROM OUR PARTNERS
OneOncology Finalizes 25 Clinical Pathways in Oncology and Hematology

OneOncology Finalizes 25 Clinical Pathways in Oncology and Hematology

AJMC Staff
October 25th 2023
ArticleFROM OUR PARTNERS
CHEA logo

Coverage in Health Equity: October 2023

Kyle Munz;Skylar Jeremias;Laura Joszt, MA;Maggie L. Shaw
October 21st 2023
Article

Health equity coverage appearing in the October 2023 issue of Evidence-Based Oncology.

Dale Porter, PhD | Image Credit: Servier

Why Failing Faster Is the Key to Accelerating Drug Discovery

Dale Porter, PhD
October 21st 2023
ArticleCOMMENTARY
EBO

COVID-19 Fallout on Individuals, Economy, and Health System to Last for Years, White Paper Concludes

Hayden E. Klein
October 20th 2023
Article
EBO logo

The Challenges of Treating Cancer When the Patient Lives Far From Care

Peter Page
October 20th 2023
ArticleCOVER FEATURE
EBO logo

Navigating Decision-Making When Treating Lymphoma With Bispecific Antibodies vs CAR T-Cell Therapy

Ryan Flinn
October 20th 2023
ArticleCOVER FEATURE
[COA seal]: credit: Community Oncology Alliance

COA Supports Bills to Ensure Access to Cancer Medications

AJMC Staff
September 20th 2023
ArticleFROM OUR PARTNERS

The endorsements follow the group's lawsuit earlier this year to overturn CMS' interpretation of the Stark Law.

EBO logo

How AI and Machine Learning Can Bring Quality Improvements in Biopharma

Bryan Abney, MS
August 28th 2023
ArticleCOMMENTARY
Denlinger

A Mission to Cure “All the Cancers”: Crystal Denlinger, MD, FACP, Named CEO of NCCN

Mary Caffrey
August 23rd 2023
ArticleCOVER FEATURE

Denlinger, who spent most of her career at Fox Chase Cancer Center before joining the National Comprehensive Cancer Network (NCCN) as its chief scientific officer, took the helm October 9, 2023.

orphan drug / Pexels

Unlocking the Benefits of FDA’s Orphan Drug Designation

Rachel Capone, MSHS
August 22nd 2023
ArticleCOMMENTARY
SAP logo | Image credit: AJMC

Verily, OneOncology Create Clinical Trial Partnership to Feature Use of SignalPath Across Practices

Mary Caffrey
August 16th 2023
ArticleFROM OUR PARTNERS

Use of SignalPath will improve efficiency, ease compliance, boost enrollment, and ensure financial success in clinical trials, leaders said in interviews.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.